v3.25.4

LEASES | 12 Months Ended
--- | ---
Dec. 31, 2024
Aspire Biopharma Inc [Member] |
LEASES | NOTE 5 - LEASES The company does not lease facilities under any operating lease arrangement. Intermittently the Company has rented office space on an as needed basis from a related party. Total rent expense for the months ended December 31, 2024 and 2023 was $6,500 and $0, respectively.

X
- Definition The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 842 -SubTopic 20 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/842-20/tableOfContent + Details
Name: | us-gaap_LesseeOperatingLeasesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_ConsolidatedEntitiesAxis=ASBP_AspireBiopharmaIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |